Oriola Oyj operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oriola Oyj with three other
drug stores in Europe:
Selcuk Ecza Deposu Ticaret ve Sanayi AS
sales of 17.81 billion Turkish Liras [US$2.16 billion]
of which 100%
was Medical and Hospital Equipment),
(1.67 billion Euros [US$1.96 billion]
of which 80%
was Supply Chain & Retail Services), and
based in POLAND
(8.28 billion Polish New Zlotys [US$2.10 billion]
of which 98%
was Pharmaceutical Wholesale).
During the year ended December of 2019, sales at
Oriola Oyj were 1.72 billion Euro (US$2.02 billion).
increase of 10.9%
versus 2018, when the company's sales were 1.55 billion Euro.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Oriola Oyj had sales
of 1.61 billion Euro.
Sales of Healthcare saw an increase
that was more than double the company's growth rate: sales were up
206.4% in 2019, from
92.50 million Euro to 283.40 million Euro.
Not all segments of Oriola Oyj experienced an increase in sales in 2019:
sales of Services fell 74.1% to 687.90 million Euro.
Oriola Oyj also experienced decreases in sales in
Consumer (down 2.5% to 750.00 million Euro)